共 29 条
[1]
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
[J].
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY,
2017, 76 (03)
:405-417
[10]
THE MORTALITY OF DOCTORS IN RELATION TO THEIR SMOKING HABITS - A PRELIMINARY REPORT
[J].
BMJ-BRITISH MEDICAL JOURNAL,
1954, 1 (4877)
:1451-1455